Testing a special MRI scan to tell dead tissue from returning glioma
Original title: MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study has no phase listed, so it is an early test of a new scan.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether a special MRI scan can tell treatment damage apart from a tumor that has come back.
Who this trial is for. This trial is for people with a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary that has already been treated. It uses a kind of MRI scan called MRE to measure how stiff or soft brain tissue is.
Where it stands. The study compares how stiff tissue hurt by radiation is with how stiff returning tumor is. It has not reported results yet.
What this means, and what it doesn't
What it could mean: Radiation damage and a returning tumor can be hard to tell apart. If this scan helps, doctors might one day make a clearer diagnosis. If you have a treated glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary, you could ask your care team about this study.
What it doesn't mean: This trial is a test of a scan, not a proven tool or a treatment. It will not treat the tumor. Being in it does not promise any benefit to you. It is not a cure.
Source: ClinicalTrials.gov, September 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.